Disseminated nocardiosis after unrelated bone marrow transplantation

Transpl Infect Dis. 2016 Dec;18(6):942-945. doi: 10.1111/tid.12617. Epub 2016 Nov 10.

Abstract

Nocardiosis is a rare bacterial infection occurring mainly in patients with deficient cell-mediated immunity. Although disseminated nocardiosis after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a rare complication, it is associated with high mortality. Moreover, after allo-HSCT, nocardiosis may be mistaken for other bacterial or fungal infections because clinical and radiographic findings of pulmonary, cerebral, and cutaneous nocardiosis lesions are non-specific. Here, we report a case of disseminated nocardiosis (caused by Nocardia abscessus) with skin, pulmonary, liver, lymph node, and multiple brain abscesses in a patient after allo-HSCT. The patient initially responded clinically and radiographically to imipenem/cilastin and trimethoprim-sulfamethoxazole therapy. Clinicians should be aware of the possibility of nocardiosis in allo-HSCT recipients who are treated with multiple immunosuppressive agents to control chronic graft-versus-host disease. Accurate diagnosis and identification of disseminated nocardiosis is important to ensure administration of the correct antibiotic regimen.

Keywords: allogeneic stem cell transplant; chronic graft-versus-host disease; disseminated nocardiosis.

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use
  • Antibiotic Prophylaxis
  • Antineoplastic Agents / therapeutic use
  • Bone Marrow Transplantation / adverse effects*
  • Brain Abscess / cerebrospinal fluid
  • Brain Abscess / diagnostic imaging
  • Brain Abscess / drug therapy
  • Brain Abscess / microbiology
  • Bronchoalveolar Lavage
  • Bronchoalveolar Lavage Fluid / microbiology
  • Bronchoscopy
  • Colitis / virology
  • Cytomegalovirus / isolation & purification
  • Female
  • Graft vs Host Disease / drug therapy*
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Leukemia, Myeloid, Acute / drug therapy
  • Leukemia, Myeloid, Acute / surgery*
  • Liver / microbiology
  • Lung / diagnostic imaging
  • Lung / microbiology
  • Magnetic Resonance Imaging
  • Middle Aged
  • Nocardia / isolation & purification*
  • Nocardia Infections / cerebrospinal fluid
  • Nocardia Infections / diagnostic imaging*
  • Nocardia Infections / drug therapy*
  • Nocardia Infections / microbiology
  • Skin / microbiology
  • Tomography, X-Ray Computed
  • Transplantation, Homologous / adverse effects
  • Unrelated Donors

Substances

  • Anti-Bacterial Agents
  • Antineoplastic Agents
  • Immunosuppressive Agents